On March 10, 2022, Chinese biopharmaceutical company I-Mab saw its share price drop by nearly 14 percentage points in U.S. stock exchange markets, while Zai Lab similarly saw its share price decrease by some nine percentage points. This statistc illustrates the share price change in select Chinese companies listed in the United States.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Evaluate Vantage. (March 11, 2022). Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage. "Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022." Chart. March 11, 2022. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage. (2022). Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage. "Share Price Change in Select Chinese Biopharmaceutical Companies Listed in The United States on March 10, 2022." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 11 Mar 2022, /statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage, Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022 ÌÇÐÄÆƽâ°æ, /statistics/1301169/us-listed-chinese-biopharma-share-price-change/ (last visited July 25, 2026)
Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022 [Graph], Evaluate Vantage, March 11, 2022. [Online]. Available: /statistics/1301169/us-listed-chinese-biopharma-share-price-change/
